Our outstanding capabilities across all facets of our business are reflected in our ability to continue to improve clinical pregnancy rates, whereby the chances of our patients having a healthy baby are now 4.5% higher compared to calendar year 2018. These results, and our commitment to driving future improvements, will be key to our goal of becoming the most admired reproductive care provider in the world.
I have touched on the impact the ongoing pandemic has had on the mindset of our patient cohort, with greater focus on family, health and wellbeing resulting in re-direction of priorities towards family extension. We expect these factors to continue to drive growth in FY22, and we will keep investing in strategic initiatives that support our future growth.
Quality without boundaries
As we grow our businesses and expand our capabilities, we are benefiting from our reputation as a leader in reproductive care in all of our markets. Monash IVF Group has been built on a culture of quality that is reflected not just in our innovative technology, but in our people, our partnerships, and our forward thinking. Maintaining a culture with quality and patient excellence at its core will ensure we continue to deliver the highest standards in the future.
Strong corporate governance
In September 2020, we appointed Ms Catherine West as Independent Non-Executive Director, who brings considerable acumen to the business with over 25 years of legal, business affairs and strategy experience in Australia, the UK and Europe. Catherine was also appointed as a member of the Remuneration and Nomination Committee.
Looking ahead to 2022 and beyond, I am very optimistic for the future of Monash IVF Group. I believe we have set ourselves the right strategic objectives and have a strong leadership team in place to deliver sustainable growth over the long term. Monash IVF Group has outstanding technology capabilities and a dedicated and passionate team working hard to deliver excellent outcomes for our patients. Over the last year, I have seen this passion and dedication first hand, and I want to take this opportunity to thank every one of the team for their hard work and commitment.
Finally, on behalf of the Board I would like to thank our shareholders for their ongoing commitment as we look forward to even greater things in FY22.